These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35680804)

  • 21. Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells.
    Lian S; Xie R; Ye Y; Lu Y; Cheng Y; Xie X; Li S; Jia L
    Sci Rep; 2019 Mar; 9(1):4532. PubMed ID: 30872703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of PD-L1 to oncogenesis of lymphoma and its RNAi-based targeting therapy.
    Li Y; Wang J; Li C; Ke XY
    Leuk Lymphoma; 2012 Oct; 53(10):2015-23. PubMed ID: 22462616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease.
    Al-Chaqmaqchi H; Sadeghi B; Abedi-Valugerdi M; Al-Hashmi S; Fares M; Kuiper R; Lundahl J; Hassan M; Moshfegh A
    PLoS One; 2013; 8(4):e60367. PubMed ID: 23593203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stromal Cell PD-L1 Inhibits CD8
    O'Malley G; Treacy O; Lynch K; Naicker SD; Leonard NA; Lohan P; Dunne PD; Ritter T; Egan LJ; Ryan AE
    Cancer Immunol Res; 2018 Nov; 6(11):1426-1441. PubMed ID: 30228206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.
    Sun JR; Zhang X; Zhang Y
    Cell Mol Biol Lett; 2019; 24():68. PubMed ID: 31844419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma.
    Lu F; Zhao Y; Pang Y; Ji M; Sun Y; Wang H; Zou J; Wang Y; Li G; Sun T; Li J; Ma D; Ye J; Ji C
    Cancer Lett; 2021 Jan; 497():178-189. PubMed ID: 33091534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 28. Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma.
    Wei T; Li M; Zhu Z; Xiong H; Shen H; Zhang H; Du Q; Li Q
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):691-701. PubMed ID: 33389078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
    Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.
    Briones J; Timmerman JM; Panicalli DL; Levy R
    J Natl Cancer Inst; 2003 Apr; 95(7):548-55. PubMed ID: 12671023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).
    Li Y; Liu H; Zhao Y; Yue D; Chen C; Li C; Zhang Z; Wang C
    Thorac Cancer; 2021 Oct; 12(20):2698-2709. PubMed ID: 34423566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
    Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
    Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor cell-intrinsic CD274/PD-L1: A novel metabolic balancing act with clinical potential.
    Clark CA; Gupta HB; Curiel TJ
    Autophagy; 2017 May; 13(5):987-988. PubMed ID: 28368722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.
    Hsu PC; Miao J; Wang YC; Zhang WQ; Yang YL; Wang CW; Yang CT; Huang Z; You J; Xu Z; Jablons DM; You L
    J Cell Mol Med; 2018 Jun; 22(6):3139-3148. PubMed ID: 29575535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.
    Li D; Sun FF; Wang D; Wang T; Peng JJ; Feng JQ; Li H; Wang C; Zhou DJ; Luo H; Fu ZQ; Zhang T
    Oncol Res; 2020 Dec; 28(5):467-481. PubMed ID: 32560747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.
    Chen BJ; Chapuy B; Ouyang J; Sun HH; Roemer MG; Xu ML; Yu H; Fletcher CD; Freeman GJ; Shipp MA; Rodig SJ
    Clin Cancer Res; 2013 Jul; 19(13):3462-73. PubMed ID: 23674495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer.
    He PX; Ma ZL; Han H; Zhang XY; Niu SH; Du LN; Zheng YC; Liu HM
    Life Sci; 2020 Feb; 242():117247. PubMed ID: 31899223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
    Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
    Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7-2 expression above a threshold elicits anti-tumor immunity as effective as interleukin-12 and prolongs survival in murine B-cell lymphoma.
    Pizzoferrato E
    Int J Cancer; 2004 May; 110(1):61-9. PubMed ID: 15054869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.